PFD report

Michael Roy Mahon · Prevention of Future Deaths report

Pin Get email alerts Request correction

Issued 15 Mar 2017•Manchester South

Report record

Published report and response evidence

This page connects the concerns raised in this report with statements found in recipients’ published responses. A link shows a clear evidence connection; it does not assign responsibility.

View original report
Concerns
1

Raised in this report

Recipients
1

Named on the report

Responses found
0

Of 1 recipient

Stated actions
0

Described in responses

Recipients and published responses

Source document

Full report text

This is the full text from the original published report.

Open published report

Concerns and recipient responses

Select any concern, action or position to view the source wording.

Report evidence summary

Concerns raised1

  1. Lack of a system to identify missed annual clozapine tests
    Part of recurring concern: Unreliable safety monitoring and guidance for clozapine treatment
Responses linked to these concerns

Each statement is shown once, even when linked to more than one concern.

No linked response statements

No respondent-stated action or position is clearly linked to these concerns.

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Lack of a system to identify missed annual clozapine tests

Wider context from the report

“In the course of the inquest I heard evidence that both annual and monthly tests should be undertaken where clozapine has been prescribed. The annual test was required to identify symptoms and potential side effects that would not necessarily be picked up on monthly tests. Michael Mahon had not had his annual test. This should have taken place in March 2016.It was accepted that there was no system to identify that the test had been missed and it was not noticed at any of his monthly checks. ”

Is this part of a recurring concern?

Yes — Unreliable safety monitoring and guidance for clozapine treatment.

Open source report
Back to top

Information checked against the published report and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations

Official responses located
0/1

Data last updated 7 September 2026

No official response is included in the current published snapshot.